Latest Bayer Schering Pharma Stories
WARRENDALE, Pa., Nov. 29, 2010 /PRNewswire/ -- MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCAREÂ®, for the MEDRAD Intego(TM) PET Infusion System.
WARRENDALE, Pa., Nov.
NEW YORK, Sept. 30 /PRNewswire/ -- The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala.
WARRENDALE, Pa., Sept. 17 /PRNewswire/ -- At MEDRAD, Inc., community outreach is a celebrated corporate tradition. This year marks MEDRAD's 11th annual Day of Caring, a company-sponsored event where employees will have the opportunity to spend a workday volunteering in their communities.
WALTHAM, Mass., Sept.
REDWOOD CITY, Calif., June 17 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc. and Bayer Schering Pharma AG, Germany, today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.
WELLESLEY HILLS, Mass., May 21 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the auction of the MRI imaging intellectual properties has been changed to June 22, 2010 at 9:00 A.M. Eastern.
WARRENDALE, Pa., May 19 /PRNewswire/ -- Today, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego(TM) PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS).
BETHESDA, Md., April 21 /PRNewswire-FirstCall/ -- Micromet, Inc.
- A transitional zone between two communities containing the characteristic species of each.